Gene Therapy - Table of Contents alert Volume 21 Issue 4

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 21, Issue 4 (April 2014) In this issue Enabling Technologies Original Articles Short Communications Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Human Genome Variation, a new Open Access, online-only journal from Nature Publishing Group and the Japan Society of Human Genetics, is launching in 2014. The journal will publish research articles and reports about variation and variability in the human genome. PUBLISH, SHARE, UTILIZE human genome data with Human Genome Variation. Learn more and register for e-alerts at www.nature.com/hgv Enabling Technologies Top An integration-defective lentivirus-based resource for site-specific targeting of an edited safe-harbour locus in the human genome R Torres, A Garcia, M Jimenez, S Rodriguez and J C Ramirez Gene Ther 2014 21: 343-352; advance online publication, February 6, 2014; 10.1038/gt.2014.1 Abstract | Full Text Original Articles Top A macrophage-specific synthetic promoter for therapeutic application of adiponectin OPEN W S Kang, J S Kwon, H B Kim, H-y Jeong, H J Kang, M H Jeong, J G Cho, J C Park, Y S Kim and Y Ahn Gene Ther 2014 21: 353-362; advance online publication, February 6, 2014; 10.1038/gt.2014.3 Abstract | Full Text Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model Z Wang, C L Halbert, D Lee, T Butts, S J Tapscott, R Storb and A D Miller Gene Ther 2014 21: 363-370; advance online publication, February 6, 2014; 10.1038/gt.2014.4 Abstract | Full Text Calpain-dependent clearance of the autophagy protein p62/SQSTM1 is a contributor to ΔPK oncolytic activity in melanoma A Colunga, D Bollino, A Schech and L Aurelian Gene Ther 2014 21: 371-378; advance online publication, February 20, 2014; 10.1038/gt.2014.6 Abstract | Full Text Effect of bortezomib on the efficacy of AAV9.SERCA2a treatment to preserve cardiac function in a rat pressure-overload model of heart failure A H Chaanine, M Nonnenmacher, E Kohlbrenner, D Jin, J C Kovacic, F G Akar, R J Hajjar and T Weber Gene Ther 2014 21: 379-386; advance online publication, February 27, 2014; 10.1038/gt.2014.7 Abstract | Full Text Gene transfer of arginine kinase to skeletal muscle using adeno-associated virus S C Forbes, L T Bish, F Ye, J Spinazzola, C Baligand, D Plant, K Vandenborne, E R Barton, H L Sweeney and G A Walter Gene Ther 2014 21: 387-392; advance online publication, February 27, 2014; 10.1038/gt.2014.9 Abstract | Full Text Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer J C Morris, C A Ramlogan-Steel, P Yu, B A Black, P Mannan, J P Allison, T A Waldmann and J C Steel Gene Ther 2014 21: 393-401; advance online publication, February 27, 2014; 10.1038/gt.2014.10 Abstract | Full Text Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity OPEN J Sivalingam, T T Phan and O L Kon Gene Ther 2014 21: 402-412; advance online publication, February 20, 2014; 10.1038/gt.2014.11 Abstract | Full Text Sonic hedgehog gene therapy increases the ability of the dystrophic skeletal muscle to regenerate after injury A Piccioni, E Gaetani, M Palladino, I Gatto, R C Smith, V Neri, M Marcantoni, I Giarretta, M Silver, S Straino, M Capogrossi, R Landolfi and R Pola Gene Ther 2014 21: 413-421; advance online publication, February 27, 2014; 10.1038/gt.2014.13 Abstract | Full Text Gene therapy for trigeminal pain in mice A Z Tzabazis, M Klukinov, D P Feliciano, S P Wilson and D C Yeomans Gene Ther 2014 21: 422-426; advance online publication, February 27, 2014; 10.1038/gt.2014.14 Abstract | Full Text Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector N Miyake, K Miyake, N Asakawa, M Yamamoto and T Shimada Gene Ther 2014 21: 427-433; advance online publication, February 27, 2014; 10.1038/gt.2014.17 Abstract | Full Text Short Communications Top Long-term in vivo imaging of translated RNAs for gene therapy K Pinel, J Lacoste, G Plane, M Ventura and F Couillaud Gene Ther 2014 21: 434-439; advance online publication, January 16, 2014; 10.1038/gt.2013.89 Abstract | Full Text Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood Y Di, L Seymour and K Fisher Gene Ther 2014 21: 440-443; advance online publication, February 20, 2014; 10.1038/gt.2014.2 Abstract | Full Text Efficient delivery of lentiviral vectors into resting human CD4 T cells X Geng, G Doitsh, Z Yang, N L K Galloway and W C Greene Gene Ther 2014 21: 444-449; advance online publication, February 27, 2014; 10.1038/gt.2014.5 Abstract | Full Text Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors P Colella, I Trapani, G Cesi, A Sommella, A Manfredi, A Puppo, C Iodice, S Rossi, F Simonelli, M Giunti, M L Bacci and A Auricchio Gene Ther 2014 21: 450-456; advance online publication, February 27, 2014; 10.1038/gt.2014.8 Abstract | Full Text Advertisement Have you read the new Cancer Gene Therapy CGT has a new editor in chief with a new vision for the journal: Steven K. Libutti, M.D. - Director of Montefiore-Einstein Center for Cancer Care - Associate Director for Clinical Services, Albert Einstein Cancer Center You can follow CGT on Twitter @cgtnature   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.